Lead Product(s) : Tolcapone
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : Hospital Vall d'Hebron
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of SOM0226 in Familial Amyloid Polyneuropathy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 16, 2014
Lead Product(s) : Tolcapone
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : Hospital Vall d'Hebron
Deal Size : Inapplicable
Deal Type : Inapplicable